Vaccine Doubts Hit Sentiment

Thursday’s session was quiet owing to most traders sitting on their hands given the Thanksgiving holiday in the US. Whilst the US markets are open for a half day, we’re not expecting much in the way of volume. Black Friday shopping is also offering another distraction.

Charts (6)

Thursday’s session was quiet owing to most traders sitting on their hands given the Thanksgiving holiday in the US.  Whilst the US markets are open for a half day, we’re not expecting much in the way of volume. Black Friday shopping is also offering another distraction.

European bourses are edging lower, as the vaccine optimism seen at the start of the week has completely fizzled now that questions are growing over the soundness of the AstraZeneca covid vaccine trial. The doubts could delay the cheap and easily transported vaccine from being approved quickly by regulators. 

The pharmaceutical giant is likely to run a new additional study to assess the efficacy of a lower dosage after a subgroup which accidentally received an initial half dose revealed the dose to be 90% effective. AstraZeneca share are trading 1% lower.

Chinese factory profits soar
Concerns over the vaccine are overshadowing news that Chinese industrial profits surged at the fastest pace since early 2017. Although the minrers are finding support from the knowledge that the recovery in the world’s largest consumer of metals was powering along nicely. This is a stark contrast to Europe and the US which are still battling to bring covid infections under control. 

UK’s gloomy outlook
The British government yesterday announced the UK Tier breakdown for when the national lockdown ends next week. With around 20 million Brits going from national lockdown to Tier 3, the toughest category the economic outlook for the UK remains particularly gloomy

Oil & gold struggle
Oil prices are declining on Friday in quiet trade amid concerns over oversupply and doubts over a vaccine to end the covid pandemic. Despite falling for a second straight session both Brent and WTI are on track to book gains in the region of 6% across the week.
Meanwhile, the risk off mood wasn’t helping gold, which continues to struggle for direction just north of $1800. 

FTSE Chart
After the FTSE’s strong run up at the start of the month on vaccine news, the rally has been consolidating in the horizontal channel of 6515 and 6325. The price is currently find support on the lower ban of the channel. A break through 6325 could open the door to a deeper selloff towards horizontal support at 6120 and then near 6000, the confluence of the 50,100 & 200 day moving average. 
Should support at 6325 hold then the FTSE could make another push towards 6500.

More from FTSE 100

Disclaimer: The information on this web site is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement. The information and opinions in this report are for general information use only and are not intended as an offer or solicitation with respect to the purchase or sale of any currency or CFD contract. All opinions and information contained in this report are subject to change without notice. This report has been prepared without regard to the specific investment objectives, financial situation and needs of any particular recipient. Any references to historical price movements or levels is informational based on our analysis and we do not represent or warranty that any such movements or levels are likely to reoccur in the future. While the information contained herein was obtained from sources believed to be reliable, author does not guarantee its accuracy or completeness, nor does author assume any liability for any direct, indirect or consequential loss that may result from the reliance by any person upon any such information or opinions.

Futures, Options on Futures, Foreign Exchange and other leveraged products involves significant risk of loss and is not suitable for all investors. Losses can exceed your deposits. Increasing leverage increases risk. Spot Gold and Silver contracts are not subject to regulation under the U.S. Commodity Exchange Act. Contracts for Difference (CFDs) are not available for US residents. Before deciding to trade forex and commodity futures, you should carefully consider your financial objectives, level of experience and risk appetite. Any opinions, news, research, analyses, prices or other information contained herein is intended as general information about the subject matter covered and is provided with the understanding that we do not provide any investment, legal, or tax advice. You should consult with appropriate counsel or other advisors on all investment, legal, or tax matters. References to Forex.com or GAIN Capital refer to GAIN Capital Holdings Inc. and its subsidiaries. Please read Characteristics and Risks of Standardized Options.